| Gowing Brothers Ltd (GOW) ORDINARY FULLY PAID |
Financials |
$115 |
Application for quotation of securities - GOW
|
23 Apr 2026 1:27PM |
$2.270 |
$2.120 |
fallen by
6.61%
|
|
| Taiton Resources Limited (T88) ORDINARY FULLY PAID |
Materials |
$7 |
Update - Proposed issue of securities - T88
|
23 Apr 2026 1:16PM |
$0.075 |
$0.057 |
fallen by
24%
|
|
| Southern Hemisphere Mining Limited (SUH) ORDINARY FULLY PAID |
Materials |
$14 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
23 Apr 2026 1:11PM |
$0.025 |
$0.019 |
fallen by
24%
|
|
SUH - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of Phase I deep-drilling program at Southern Porphyry target.
- Significant mineralization results indicating proximity to a porphyry core.
- Phase II drilling to target the high-grade porphyry core.
- Net cash outflow from operating activities of $473,000 for the quarter.
- JV partner FMR Resources Limited contributed $999,000 towards drilling expenses.
- End of quarter cash balance of $999,000 with a $0.5 million drawdown facility.
- Outlook includes further drilling and assay activities in the next quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pinnacle Minerals Limited (PIM) ORDINARY FULLY PAID |
Materials |
$5 |
Quarterly Activity and Cashflow Report
|
23 Apr 2026 1:07PM |
$0.042 |
$0.044 |
risen by
4.76%
|
|
PIM - Price-sensitive ASX Announcement
Full Release
Key Points
- Pinnacle streamlined its portfolio, terminating U.S. projects without financial impact.
- Retained core projects in Australia and Canada in good standing.
- Appointment of Ari Zaetz as Non-Executive Director strengthened the board.
- Quarter ended with cash and cash equivalents of approximately A$2.56 million.
- Strategic review to unlock value across retained assets is ongoing.
- Focus on new opportunities in critical minerals, precious metals, and battery minerals.
- Emphasis on disciplined capital management and strategic partnerships.
- No on-ground exploration at Adina East during the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cambium Bio Limited (CMB) ORDINARY FULLY PAID |
Health Care |
$12 |
FDA Confirms Single Pivotal Trial Pathway for Elate Ocular
|
23 Apr 2026 1:01PM |
$0.385 |
$0.435 |
risen by
12.99%
|
|
CMB - Price-sensitive ASX Announcement
Full Release
Key Points
- FDA confirms single-trial pathway for Elate Ocular®.
- Significant reduction in development cost and accelerated timeline.
- Increased probability of success with a single well-powered study.
- Phase 3 study design confirmed with 400 evaluable subjects.
- Fast Track Designation allows rolling BLA submission.
- Focus on initiating pivotal Phase 3 study with enrolment in 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Norwood Systems Limited (NOR) ORDINARY FULLY PAID |
Information Technology |
$6 |
Norwood secures additional working capital funding of $80k
|
23 Apr 2026 1:00PM |
$0.011 |
$0.011 |
fallen by
0%
|
|
NOR - Price-sensitive ASX Announcement
Full Release
Key Points
- Norwood Systems Limited secured an additional $80,000 in working capital funding.
- The funding agreement is with Plough Lane Superannuation Pty Ltd.
- The interest rate on the loan is 9.75%.
- Repayment is due by 30 June 2026.
- An establishment fee of 4% plus GST is applicable.
- The loan is unsecured.
- Dr John Tarrant is a key figure associated with the lender.
- Paul Ostergaard, Managing Director, thanked Dr Tarrant for the support.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ADX Energy Ltd (ADX) ORDINARY FULLY PAID |
Energy |
$22 |
ADX Webinar Presentation
|
23 Apr 2026 12:54PM |
$0.030 |
$0.025 |
fallen by
16.67%
|
|
| Taiton Resources Limited (T88) ORDINARY FULLY PAID |
Materials |
$7 |
Update - Proposed issue of securities - T88
|
23 Apr 2026 12:51PM |
$0.079 |
$0.057 |
fallen by
27.85%
|
|
| N1 Holdings Limited (N1H) ORDINARY FULLY PAID |
Financials |
$8 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
23 Apr 2026 12:48PM |
$0.100 |
$0.090 |
fallen by
10%
|
|
N1H - Price-sensitive ASX Announcement
Full Release
Key Points
- Record settlement volumes achieved in the March 2026 quarter, driving strong performance across revenue, net profit, and cash receipts.
- The company maintained a consistent origination strategy despite challenging market conditions marked by interest rate increases and geopolitical uncertainty.
- Net profit for FYTD before income tax was approximately $1,351,000 (unaudited) with EBITDA of $1,582,000 (unaudited).
- Revenue for FYTD was $15.96 million (unaudited), an 8.87% increase from the previous year.
- Significant contributions from the SME lending business, which accounted for 95% of total cash receipts.
- Net cash outflow from operating activities for Q3 FY26 was $25.95 million, adjusted to an inflow of $1.98 million excluding commercial lending activities.
- Cash balance at the end of the quarter was $8.89 million.
- Operational costs remained stable, supported by AI initiatives improving efficiency and scalability.
- The company is positioned as a property-backed private credit lender in the Australian SMEs sector, with unique competitive advantages.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Racura Oncology Ltd (RAC) ORDINARY FULLY PAID |
Health Care |
$496 |
Application for quotation of securities - RAC
|
23 Apr 2026 12:42PM |
$3.020 |
$2.580 |
fallen by
14.57%
|
|
| Hawk Resources Limited (HWK) ORDINARY FULLY PAID |
Materials |
$19 |
April 2026 Corporate Presentation
|
23 Apr 2026 12:35PM |
$0.032 |
$0.030 |
fallen by
6.25%
|
|
| Revolver Resources Holdings Ltd (RRR) ORDINARY FULLY PAID |
Materials |
$21 |
Change of Extraordinary General Meeting Date
|
23 Apr 2026 12:34PM |
$0.068 |
$0.069 |
risen by
0.74%
|
|
| Xstate Resources Limited (XST) ORDINARY FULLY PAID |
Energy |
$9 |
Application for quotation of securities - XST
|
23 Apr 2026 12:34PM |
$0.032 |
$0.018 |
fallen by
43.75%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$48 |
EGM Results and Share Purchase Plan Final Allotment
|
23 Apr 2026 12:32PM |
$0.135 |
$0.115 |
fallen by
14.81%
|
|
| Perpetual Credit Income Trust (PCI) ORDINARY UNITS FULLY PAID |
Financials |
$793 |
Daily Net Tangible Asset Statement
|
23 Apr 2026 12:29PM |
$1.100 |
$1.085 |
fallen by
1.36%
|
|
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$99 |
Net Tangible Asset Backing - 22 April 2026
|
23 Apr 2026 12:24PM |
$0.710 |
$0.700 |
fallen by
1.41%
|
|
| Wide Open Agriculture Ltd (WOA) ORDINARY FULLY PAID |
Consumer Staple |
$9 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
23 Apr 2026 12:22PM |
$0.015 |
$0.013 |
fallen by
13.33%
|
|
WOA - Price-sensitive ASX Announcement
Full Release
Key Points
- Reduction in lupin protein production at the German facility.
- Investigation into a contract manufacturing model.
- Higher revenue from toll manufacturing.
- Technical trials to optimize production processes.
- Receipt of significant R&D tax rebate.
- Focus on economic expansion of lupin platform.
- Building long-term customer relationships.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alternative Investment Trust (AIQ) ORDINARY UNITS FULLY PAID |
Financials |
$83 |
AIQ NTA Factsheet March 2026
|
23 Apr 2026 12:20PM |
$1.400 |
$1.380 |
fallen by
1.43%
|
|
| Imagion Biosystems Limited (IBX) ORDINARY FULLY PAID |
Health Care |
$8 |
Appendix 4C and Quarterly Activities Report - March 2026
|
23 Apr 2026 12:16PM |
$0.022 |
$0.016 |
fallen by
27.27%
|
|
IBX - Price-sensitive ASX Announcement
Full Release
Key Points
- IND application submitted for Phase 2 HER2 breast cancer trials.
- Clinical-study site engagements completed in the USA.
- Operating cash outflow of AU$1.279 million reported.
- Cash balance of AU$0.273 million as of 31 March 2026.
- AU$11.08 million finance facility unused.
- Convertible note agreement with Mercer Street amended.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adairs Limited (ADH) ORDINARY FULLY PAID |
Consumer Discretionary |
$245 |
Company Secretary Appointment/Resignation
|
23 Apr 2026 12:09PM |
$1.260 |
$1.370 |
risen by
8.73%
|
|
| Vertex Minerals Limited (VTX) ORDINARY FULLY PAID |
Materials |
$37 |
Notification of ASX Listing Rule Matters Convertible Notes
|
23 Apr 2026 12:09PM |
$0.175 |
$0.130 |
fallen by
25.71%
|
|
| Vertex Minerals Limited (VTX) ORDINARY FULLY PAID |
Materials |
$37 |
Notification regarding unquoted securities - VTX
|
23 Apr 2026 12:09PM |
$0.175 |
$0.130 |
fallen by
25.71%
|
|
| Greatland Resources Limited (GGP) ORDINARY FULLY PAID |
Materials |
$9,209 |
March 2026 Quarter Results and Webcast
|
23 Apr 2026 12:09PM |
$14.260 |
$13.650 |
fallen by
4.28%
|
|
| Qoria Limited (QOR) ORDINARY FULLY PAID |
Information Technology |
$412 |
Qoria Q3 FY26 Results Webinar
|
23 Apr 2026 12:06PM |
$0.333 |
$0.300 |
fallen by
9.77%
|
|
| Hawsons Iron Ltd (HIO) ORDINARY FULLY PAID |
Materials |
$16 |
Results of Meeting
|
23 Apr 2026 12:04PM |
$0.017 |
$0.013 |
fallen by
23.53%
|
|